
Anbio Biotechnology
Anbio Biotechnology is an innovative and reliable supplier for laboratory and POCT diagnostic instruments and assays for the detection of biomarkers associated with a wide arrange of diseases.
诊断产品开发及医疗器械公司:安比奥生技 Anbio …
2025年1月1日 · Anbio Biotechnology (Anbio) 是一家全球领先的 医疗器械公司 ,专注于体外诊断。公司的目标是通过个性化和分散当前的诊断解决方案来彻底改变诊断市场,从而实现快速诊断并改善患者预后。
Anbio Biotechnology - LinkedIn
Anbio Biotechnology (Anbio) is a leading global medical device company with a focus on in vitrodiagnostics. Our goal is to revolutionize the diagnostics market by...
Anbio Biotechnology Unveils Dry Chemiluminescence …
FRANKFURT, Germany, Jan. 9, 2025 /PRNewswire/ -- Anbio Biotechnology ("Anbio"), a global leader in diagnostics innovation, announces the launch of its Dry Chemiluminescence Immunoassay (CLIA)...
Anbio Biotechnology Limited | IPOScoop
2025年2月18日 · Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions.
医药快讯 | 2025首家IVD企业成功上市;飞利浦CEO预告裁员;西安一医院急救推车里有过期药品,停业整顿_公司_Anbio…
2025年2月21日 · Anbio IPO定价为每股5美元,发行160万股A类普通股,成功募资800万美元。 Anbio股票于2025年2月19日在纳斯达克全球市场正式挂牌交易,交易代码为NNNN,交割时间为2月20日。
Anbio Biotechnology 寻求在美国上市,推出体外诊断产品 | 投资 …
2025年1月3日 · Anbio Biotechnology 业务 总部位于德国法兰克福的 Anbio Biotechnology 成立旨在专注于非处方、即时诊断和实验室应用的体外诊断 [IVD] 市场。 管理层由首席执行官 Michael Lau 领导,他自 2021 年 11 月以来一直在该公司任职,之前曾担任 Genscript Biotech Corp. (OTCPK:GNNSF) 的副总裁 ...
ABOUT ANBIO
Anbio Biotechnology (Anbio) is a leading global medical device company with a focus on in vitro diagnostics. Our goal is to revolutionize the diagnostics market by personalizing and decentralizing current diagnostic solutions, enabling rapid …
Anbio Biotechnology - ADLM 2024
Anbio Biotechnology (Anbio) is a leading global medical device company with a focus on in vitro diagnostics. We offer cutting-edge laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions that are rapid, accessible, and affordable on a global scale.
Anbio Biotechnology: NNNN IPO, Health Care - Developer of in …
At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs. Our comprehensive range of products encompasses solutions for various applications, including over-the-counter (OTC) utilization, point-of-care (POCT) settings, and laboratory applications.